- Home
- MTVA vs PT Comparison
MTVA vs PT Comparison
Compare MTVA & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- PT
- Stock Information
- Founded
- MTVA 2014
- PT 2012
- Country
- MTVA United States
- PT China
- Employees
- MTVA N/A
- PT N/A
- Industry
- MTVA
- PT Computer Software: Programming Data Processing
- Sector
- MTVA
- PT Technology
- Exchange
- MTVA NYSE
- PT Nasdaq
- Market Cap
- MTVA 16.8M
- PT 14.8M
- IPO Year
- MTVA N/A
- PT 2018
- Fundamental
- Price
- MTVA $1.74
- PT $0.95
- Analyst Decision
- MTVA Strong Buy
- PT
- Analyst Count
- MTVA 1
- PT 0
- Target Price
- MTVA $12.00
- PT N/A
- AVG Volume (30 Days)
- MTVA 57.9K
- PT 18.8K
- Earning Date
- MTVA 03-27-2025
- PT 11-08-2024
- Dividend Yield
- MTVA N/A
- PT N/A
- EPS Growth
- MTVA N/A
- PT N/A
- EPS
- MTVA N/A
- PT N/A
- Revenue
- MTVA N/A
- PT $4,479,352.00
- Revenue This Year
- MTVA N/A
- PT N/A
- Revenue Next Year
- MTVA N/A
- PT N/A
- P/E Ratio
- MTVA N/A
- PT N/A
- Revenue Growth
- MTVA N/A
- PT N/A
- 52 Week Low
- MTVA $1.51
- PT $0.71
- 52 Week High
- MTVA $6.75
- PT $1.27
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- PT 47.63
- Support Level
- MTVA N/A
- PT $0.93
- Resistance Level
- MTVA N/A
- PT $1.01
- Average True Range (ATR)
- MTVA 0.00
- PT 0.07
- MACD
- MTVA 0.00
- PT -0.00
- Stochastic Oscillator
- MTVA 0.00
- PT 73.85
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.